Hypertension

This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics  and renal denervation therapy. 

News | EP Lab

August 3, 2021 — Long-term follow-up data on hypertensive patients from the control group of the MODERATO II study who ...

Home August 03, 2021
Home
The Record Paradise RDN catheter uses a balloon catheter filled with water to cool the vessel wall as ultrasound-based ablation energy is delivered. It delivers a ring of ablative energy to a depth of 1-6 mm. Kirtane said it requires 2-3 sonications lasting 7 seconds each in each of the main renal arteries. #ACC21 #ACC2021 #RDN
Feature | Hypertension | By Dave Fornell, Editor

May 16, 2021 — Two months after undergoing renal denervation (RDN) with the ReCor Paradise renal denervation system ...

Home May 16, 2021
Home
News | Renal Denervation

December 9, 2020 — SoniVie, an Israeli company developing the Therapeutic Intra-Vascular Ultrasound (TIVUS) System to ...

Home December 09, 2020
Home
News | Hypertension

July 15, 2020 – Omron Healthcare Inc. and Mount Sinai Health System, New York City’s largest academic medical system ...

Home July 15, 2020
Home
News | Hypertension

April 30, 2020 — A large study in adolescents and children, some as young as 3 years of age, shows a link between ...

Home April 30, 2020
Home
News | Coronavirus (COVID-19)

April 8, 2020 — There has been debate in the past month or so during the novel coronavirus (COVID-19) pandemic whether ...

Home April 08, 2020
Home
News | Renal Denervation

April 1, 2020 — Three months after undergoing renal denervation (RDN), patients with untreated high blood pressure had ...

Home April 01, 2020
Home
News | Renal Denervation

April 1, 2020 — Three months after undergoing renal denervation (RDN), patients with untreated high blood pressure had ...

Home April 01, 2020
Home
News | Hypertension

February 27, 2020 — Aria CV Inc. completed a $31 million Series B round of financing to fund its first clinical study in ...

Home February 27, 2020
Home
News | Hypertension

February 7, 2020 — The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the Aria ...

Home February 07, 2020
Home
News | Hypertension

October 10. 2019 — Late-breaking results from its MODERATO II double-blind, randomized study of BackBeat Cardiac ...

Home October 10, 2019
Home
News | Hypertension

August 20, 2019 — In a study that spanned two and a half decades and looked at data from more than 4,700 participants ...

Home August 20, 2019
Home
Technology | Heart Failure

August 19, 2019 — The U.S. Food and Drug Administration (FDA) granted market clearance the Barostim Neo System for the ...

Home August 19, 2019
Home
Subscribe Now